RHV LOgo
10 Years of Launching Great Companies
Newsletter Summer 2010

Robin Hood is proud to announce that we recently celebrated our 10th year as an early stage investment group focusing on technology companies in the Greater Philadelphia Region.
Founded in 1999 by Rob Weber and George Marks, nine brave souls (Chuck Bonza, Larry Brotzge, Albert Charpentier, John Englesson, Tim Flatley, George Marks, John Moran, Gary Rawding, Rob Weber) met in Chesterbrook in November 1999 to compare deal flow and operating principles.

Since that time, the group has experienced economic peaks and busts, various "hot" industries, VC trends and the formation of other angel groups in the region.

Through the 10 years, the group has continued to evolve in an entrepreneurial fashion, but has held true to core principles: Invest in businesses we know and understand, invest in a way that gets deals done, and to be a highly effective forum to invest in early-stage companies in a professional manner.

The last few months have been no exception. We recently completed investments in two new portfolio companies and follow-on investments in three companies, for a total investment over $900k. We are now at 30 members, and have invested $11M in over 30 companies in the Philadelphia region.

In This Issue
  • New Investments
  • Recent follow-on Investments
  • Robin Hood establishes a presence in the Science Center
  • Robin Hood Welcomes new members
  • About Robin Hood Ventures

  • Recent follow-on Investments

    Robin Hood Ventures has completed three follow-on investments this summer.

    Maverick Network Solutions provides advanced payment solutions to corporations that help reduce costs and increase revenues. Maverick provides corporate clients with access to the national bank card networks through a wide range of payment solutions including private label debit cards, prepaid corporate gift cards and employee incentive cards.

    Molecular Detection Inc. (MDI), is developing and commercializing a portfolio of sample to answer Detect-Ready (TM) molecular diagnostic tests for detection of infectious diseases. The first product, currently in full time hospital use in the European Union, is a ready-to-use rapid detection DNA-probe screening test for MRSA infection.

    Core Essence Orthopaedics, Inc. (CE Ortho) is a privately held orthopaedic device company focused on the development, manufacture and commercialization of solutions for minimally invasive soft tissue and arthroscopic musculoskeletal repair for the extremity market. CE Ortho's intuitive and innovative technologies are driven by increasing demands for alternatives to complicated surgical procedures. CE Ortho devices enable surgeons to build on classic and familiar surgical techniques with novel instruments and implants that simplify procedures and can be mastered quickly. The Company's proprietary technologies provide solutions to the growing volume of tendon and ligament repairs required by the active lifestyles of patients of all ages.


    Robin Hood establishes a presence in the Science Center

    We are delighted to announce that we have established a presence in the Science Center Port Business Incubator. By locating in this environment, this brings us even closer to the entrepreneurs in the community. And this enables the Science Center's emerging companies to have access to a crucial piece of the start-up puzzle - funders.


    Robin Hood Welcomes new members

    Robin Hood Ventures welcomes several new members: Michael Croce, Chris Gatti, Greg Harriman, Dave Kurtz, Rudy Wolfs, and Randy Warren.


    About Robin Hood Ventures

    Robin Hood Ventures is a group of angel investors, focused on early-stage, high-growth companies in the Greater Philadelphia region. We help entrepreneurs build great companies, providing capital, mentoring, expertise and connections to help companies reach their potential. Robin Hood generally invests $250k to $500k, and collaborates with angels, institutions and VCs in our network. We invest as a single entity in businesses we know and understand, in a way that gets deals done. Since 1999, we have invested over $11M in over 30 companies in industries including software, medical devices, biotech, internet and financial technology.


    New Investments

    QRPharma Headquartered in Radnor, Pennsylvania, QR Pharma, Inc. is a clinical-stage specialty pharmaceutical company committed to developing therapeutics with novel approaches for the treatment of cognitive impairment and Alzheimer's disease. QR currently has two product development programs based on oral small-module, blood-brain barrier passable therapeutics that target two distinct pathways for the treatment of AD.

    ColdLight Solutions LLC delivers a new generation of smarter decision making where people and technology work together, in real time, to make critical business decisions. Using advanced machine intelligence to automate the process of complex data analysis, we simplify the process of data analysis putting prescriptive, actionable recommendations in the hands of the business person who can take action..

    Quick Links...

    To apply for funding

    RHV in the News

    To learn about becoming a member

    To learn about the Robin Hood portfolio



    Join our mailing list!
    Email Marketing by